Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Vanguard Index FdsTotal Stock Market | 1,038,550 | 1,038,550 | 0 | $315.65M | $340.82M | 21.97% | +$25.17M |
| Brookfield CorporationCL A(BN) | 2,330,830 | 2,330,830 | 0 | $144.16M | $159.85M | 10.30% | +$15.69M |
| Asml Holding N VN Y REGISTRY SHS N Y REGISTRY SHS | 165,836 | 145,836 | -20,000 | $132.90M | $141.18M | 9.10% | +$8.28M |
| Mirum Pharmaceuticals, Inc.(MIRM) | 1,500,055 | 1,264,028 | -236,027 | $76.34M | $92.67M | 5.97% | +$16.33M |
| Edgewise Therapeutics, Inc.(EWTX) | 5,350,000 | 5,350,000 | 0 | $70.14M | $86.78M | 5.59% | +$16.64M |
| Salesforce, Inc.(CRM) | 330,187 | 330,187 | 0 | $90.04M | $78.25M | 5.04% | -$11.78M |
| Merus N V | 750,000 | 750,000 | 0 | $39.45M | $70.61M | 4.55% | +$31.16M |
| Crinetics Pharmaceuticals In | 1,550,000 | 1,625,000 | +75,000 | $44.58M | $67.68M | 4.36% | +$23.10M |
| Viridian Therapeutics, Inc.(VRDN) | 2,380,000 | 2,380,000 | 0 | $33.27M | $51.36M | 3.31% | +$18.09M |
| Alibaba Group Holding LimitedADS(BABA) | 372,327 | 257,327 | -115,000 | $42.23M | $45.99M | 2.96% | +$3.77M |
| Zenas BioPharma, Inc.(ZBIO) | 2,250,000 | 2,000,000 | -250,000 | $21.80M | $44.40M | 2.86% | +$22.60M |
| Pharvaris N V COM | 1,725,000 | 1,750,000 | +25,000 | $30.36M | $43.66M | 2.81% | +$13.30M |
| Recursion Pharmaceuticals, Inc.CL A(RXRX) | 9,665,128 | 7,929,835 | -1,735,293 | $48.91M | $38.70M | 2.49% | -$10.21M |
| ArriVent BioPharma, Inc.(AVBP) | 1,872,142 | 1,942,142 | +70,000 | $40.76M | $35.83M | 2.31% | -$4.92M |
| BioMarin Pharmaceutical Inc.(BMRN) | 660,000 | 660,000 | 0 | $36.28M | $35.75M | 2.30% | -$534.6K |
| Vaxcyte, Inc.(PCVX) | 916,160 | 916,160 | 0 | $29.78M | $33.00M | 2.13% | +$3.22M |
| Celldex Therapeutics, Inc.(CLDX) | 1,200,000 | 1,200,000 | 0 | $24.42M | $31.04M | 2.00% | +$6.62M |
| Enliven Therapeutics Inc | 1,084,432 | 1,426,260 | +341,828 | $21.75M | $29.20M | 1.88% | +$7.44M |
| Insmed Incorporated(INSM) | 680,000 | 200,000 | -480,000 | $68.44M | $28.80M | 1.86% | -$39.63M |
| Valneva SEADS(VALN) | 2,375,000 | 2,345,000 | -30,000 | $13.47M | $28.61M | 1.84% | +$15.14M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 0 | 1,961,317 | +1,961,317 | $0 | $22.71M | 1.46% | +$22.71M |
| Apogee Therapeutics Inc | 449,392 | 500,000 | +50,608 | $19.52M | $19.86M | 1.28% | +$347.9K |
| 4d Molecular Therapeutics In | 2,000,000 | 2,000,000 | 0 | $7.42M | $17.38M | 1.12% | +$9.96M |
| LanzaTech Global, Inc.(LNZA) | 0 | 158,148 | +158,148 | $0 | $3.88M | 0.25% | +$3.88M |
| Marqeta, Inc.CL A(MQ) | 441,558 | 441,558 | 0 | $2.57M | $2.33M | 0.15% | -$242.9K |
| Io Biotech Inc | 3,354,449 | 2,512,453 | -841,996 | $4.66M | $912.3K | 0.06% | -$3.75M |
| Damora Therapeutics, Inc.(DMRA) | 99,913 | 86,579 | -13,334 | $340.7K | $322.1K | 0.02% | -$18.6K |
| AbCellera Biologics Inc.(ABCL) | 652,529 | 0 | -652,529 | $2.24M | $0 | — | -$2.24M |
| Blueprint Medicines Corp | 264,956 | 0 | -264,956 | $33.96M | $0 | — | -$33.96M |
| CeriBell, Inc.(CBLL) | 900,000 | 0 | -900,000 | $16.86M | $0 | — | -$16.86M |
| LanzaTech Global, Inc.(LNZA) | 15,814,845 | 0 | -15,814,845 | $4.29M | $0 | — | -$4.29M |